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Abstract
Background: Hyperphosphatemia, also known as excess phosphate in the blood, is a problem
that continually causes health issues for the outpatient hemodialysis population.
Hyperphosphatemia yields multiple health comorbidities and can increase mortality (Rastogi et
al., 2021).
Purpose: Hyperphosphatemia is directly correlated with end-stage renal disease (ESRD) (Goyal
& Jialal, 2020). This project aimed to decrease the incidence of hyperphosphatemia in the
chronic outpatient hemodialysis setting. The primary objective of this project was to increase
adherence levels to diet, drinks, drugs, and dialysis (4Ds) in those receiving chronic outpatient
hemodialysis in the pursuance of achieving and maintaining blood serum phosphorus levels
between 3.0 and 5.5 mg/dL as recommended by the Centers for Medicare and Medicaid
Services. Participation in a standardized motivational education program will aid in lowering
phosphorus levels in those on hemodialysis, therefore reducing morbidity and mortality. As a
result, this project implements and evaluates how delivering effective teaching will lower the
occurrence of hyperphosphatemia in the ESRD population.
Methods: This was an eight-week quality improvement project. A total of ten participants were
followed. Pre-intervention and post-intervention questionnaires were administered. During this
project, blood serum phosphorus levels were taken at three different time points: before, during
(interim), and after the 4Ds patient teaching intervention. The final factor considered for this
study was if the 4Ds patient teaching intervention had any impact on dialysis treatment
compliance rates.
Results: There was a statistically significant difference (W = 51.0, p = 0.019) between preassessment and post-assessment performance with the average pre-assessment score of 66 out of
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100 (standard deviation 19.1) and the average post-assessment score of 78 (standard deviation
13.2). The average phosphorus level before the intervention was 7.3 mg/dL (standard deviation
1.5) with a mid-intervention level of 6.2 mg/dL (standard deviation 2.2), and a post-intervention
mean phosphorus level of 6.9 mg/dL (standard deviation of 2.4), no statistical difference was
noted (H = 1.47, p = 0.479). The intervention had no impact on dialysis treatment compliance
rates.
Conclusion: The main significant finding of this project was the increase in patient knowledge
about phosphorus. Results of the project showed sufficient evidence that the median postquestionnaire score was significantly higher compared to the median pre-intervention score.
While this project adds to the existing data supporting the utilization of regularized patient
education to increase awareness of phosphate control in the ESRD population, further research is
warranted to determine if this intervention can decrease the incidence of hyperphosphatemia for
these patients on a long-term basis. Future studies could aid in determining the significance of
this project’s findings as well as help to ascertain if the limitations of this project are substantial
enough to alter patient outcomes.
Keywords: hyperphosphatemia, end-stage renal disease, patient education, 4Ds
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Implementing the 4Ds (Diet, Drinks, Drugs, and Dialysis) to Lower Hyperphosphatemia
Among Outpatient Hemodialysis Patients
Hyperphosphatemia is defined as excess phosphate in the blood and is a common and
chronic condition found in patients receiving hemodialysis for end-stage renal disease (ESRD)
(Goyal & Jialal, 2020). According to Rastogi et al. (2021), by the time a patient begins
hemodialysis, statistics reflect many of them will already have hyperphosphatemia. Chronic
hyperphosphatemia leads to multiple health comorbidities and increases patient mortality
(Rastogi et al., 2021). One study by Karavetian and Rizk (2018) argued that rather than finding
new treatments for hyperphosphatemia, delivering existing therapies, which include diet, drinks
drugs, and dialysis, in a more effective manner is the best approach for combatting this
troublesome issue.
There is limited data available describing the best approaches to controlling blood serum
phosphate levels in patients with ESRD; however, Waheed, et al. (2013), describe the
importance of diet as a primary source of phosphorus contributing to hyperphosphatemia in
patients with ESRD. Given the role of phosphate intake in blood serum levels, an intervention
focusing on compliance with a restricted-phosphorus diet regimen may prove effective (Waheed
et al., 2013). This Doctor of Nursing Practice (DNP) project evaluated the effects of informative
teaching on how it relates to lowering elevated blood serum phosphorus levels, in end-stage renal
disease patients. More specifically, how does this intervention impact those with ESRD
currently receiving hemodialysis in the chronic outpatient setting?
Background
Chronic kidney disease (CKD) is a prevalent condition in which the kidneys are
damaged, resulting in a decrease in the filtration of the blood through the glomerulus (Centers for
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Disease Control and Prevention (CDC, 2021). This allows excess fluid and waste from the blood
to remain in the body, thus leading to, sometimes extensive, vascular, cardiac, neurological, and
integumentary problems. It is estimated that around 37 million people, or 15% of adults in the
United States (U.S.), have CKD. Of these, approximately 558,000 have progressed to ESRD and
are treated through regular dialysis which can lead to multiple comorbidities, including
hyperphosphatemia (Centers for Disease Control, 2021).
Why Hyperphosphatemia Occurs in People with ESRD
According to Goyal and Jialal (2020), phosphorus is in most of the foods and drinks
consumed by individuals in the United States on a daily basis. Phosphorus is absorbed into the
bloodstream through the upper small intestine during the digestion process. Once absorbed,
excess phosphorus is excreted from the body in urine produced by the kidneys. Those without
reduced renal function do not excrete the excess phosphorus from the body, which can result in
phosphorus accumulation in the blood leading to hyperphosphatemia. (Goyal & Jialal, 2020).
Why People on Hemodialysis have Hyperphosphatemia
The normal adult consumes approximately 1,000 milligrams of phosphorus per day,
while hemodialysis removes approximately 900 milligrams of phosphorus with each treatment
(Goyal & Jialal, 2020). Each patient on hemodialysis typically receives three hemodialysis
treatments per week. Thus, on average, each patient on hemodialysis will consume
approximately 7,000 milligrams of phosphorus weekly with only 2,700 milligrams removed via
hemodialysis over that same time frame (Goyal & Jialal, 2020).
Health Risks Associated with Hyperphosphatemia
When hyperphosphatemia is left untreated it leads to the subsequent development of
multiple health comorbidities and even increases mortality (Rastogi et al., 2021). Uncontrolled
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longstanding hyperphosphatemia results in deposits of calcium-phosphate complexes throughout
the body resulting in vascular calcification and arteriosclerosis (Goyal & Jialal, 2020). Lack of
vasculature flexibility can lead to systolic hypertension, widened pulse pressure, and left
ventricular hypertrophy (Goyal & Jialal, 2020). Other problems associated with uncontrolled
hyperphosphatemia include severe pruritis, poor bone health, and painful debilitating skin ulcers
known as calciphylaxis (Goyal & Jialal, 2020).
Ways to Control Phosphorus
Three approaches exist to control serum phosphorus levels in patients with ESRD on
hemodialysis. First, patients must lower phosphorus in the diet by avoiding or limiting foods
higher in phosphorus. Foods lower in phosphorus include fresh fruits, fresh vegetables, rice,
fish, chicken, and light-colored sodas (Elkins, 2015). Foods higher in phosphorus include dairy
products, beans, nuts, processed meats, fast food, and dark-colored sodas (Elkins, 2015).
Another way to control phosphorus is through pharmacological intervention. Oral phosphatebinding medications are used to lower phosphorus levels. Examples of these medications include
Tums, Fosrenol, Renvela, PhosLo, and Auryxia (Gilbert & Weiner, 2017). Phosphate binders
work by adhering to phosphorus in the gut during the digestion process. Once bound by the
medication, phosphorus is not absorbed and, instead, excreted from the body via stool. To be
effective, these medications must be taken while the patient is eating. The last way to control
phosphorus is through hemodialysis (Goyal & Jialal, 2020).
Needs Analysis
More than 100,000 individuals in the U.S. begin hemodialysis annually (Centers for
Medicare and Medicaid Services, 2020). Currently, 114 billion dollars per year, or 20% of the
Medicare budget, is spent on patients with some degree of kidney disease (Centers for Medicare
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and Medicaid Services, 2020). Between 50% and 74% of all patients on hemodialysis in the
U.S. have hyperphosphatemia (Goyal & Jialal, 2020). According to Rastogi et al. (2021), by the
time a patient begins hemodialysis, they are highly likely to already have hyperphosphatemia,
and the trend continues thereafter. Controlling a patient’s phosphorus level can be challenging to
providers, given that so much of the problem is dependent upon patient adherence. (Goyal &
Jialal, 2020).
Uncontrolled hyperphosphatemia leads to greater hospitalization rates due to its effects
on the cardiovascular system (Fishbane & Nigwekar, 2021). Longstanding hyperphosphatemia
carries with it many negative adverse consequences which can affect a patient’s integumentary
system, cardiac system, central nervous system, and visual system (Goyal & Jialal, 2020). Those
with hyperphosphatemia also carry up to eight times a greater mortality risk than patients with
phosphorus levels within the normal limits (Fishbane & Nigwekar, 2021). Other problems
associated with uncontrolled hyperphosphatemia include severe pruritis, poor bone health, and
painful debilitating skin ulcers known as calciphylaxis (Goyal & Jialal, 2020).
In 1972, President Nixon signed a Social Security amendment that extended Medicare
coverage to those with chronic kidney failure (National Academy of Sciences, 1991). As a
result, patients with ESRD are automatically eligible for Medicare benefits, reducing the burden
of insurance coverage for the patient. This is beneficial to the patient but not beneficial to the
Medicare budget. According to the United States Renal Data System’s annual report,
hemodialysis care cost Medicare $93,191 in 2020 for each patient (United States Renal Data
System (USRDS), 2021). This adds up to over $50.0B annually, or 7 2% of Medicare’s entire
budget (USRDS, 2021). Under the Affordable Care Act enacted in March 2010, patients on
hemodialysis are included in a “bundle” plan which covers some of the specialized medications
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required. These expenses, compiled with the cost of treating the comorbidities associated with
longstanding uncontrolled hyperphosphatemia, make the financial burden even for significant
(White et al., 2006). For this reason, Medicare has put in place the ESRD Quality Incentive
Program (QIP) in which part of these standards are based on blood serum phosphorus levels
(Centers for Medicare and Medicaid Services 2014). In this program, each outpatient facility
that provides care for patients with ESRD is scored on the quality of the care it provides (CMS,
2014). Thus, facilities that do not provide the level of care that meets Medicare’s standards are
paid less for services rendered (CMS, 2014).
Maintaining bone and mineral homeostasis is a crucial aspect of providing care since a
normal phosphorus level improves a patient’s quality of life and longevity (Fishbane &
Nigwekar, 2021). Although this troublesome issue is well documented in the literature and
understood by providers (Gilbert & Weiner, 2017), maintaining normal phosphorus levels
continues to be a problem. For example, at the outpatient hemodialysis facility where this
project was conducted, over 50% of the patient census had a diagnosis of hyperphosphatemia.
The current practice at this facility for helping to control phosphorus is randomized teaching. It
is for these reasons that this topic and intervention were chosen for this project.
Problem Statement
Hyperphosphatemia is directly correlated with ESRD which leads to further patient
complications (Goyal & Jialal, 2020). As a result, this project implements and evaluates how
delivering effective teaching will lower the occurrence of hyperphosphatemia in the ESRD
population in the pursuance of increasing compliance with recommended and prescribed
treatment regimens.
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Aims and Objectives
The goal of this project was to reduce the incidence of hyperphosphatemia in this
population. In the pursuance of achieving this outcome, this project implemented evidencebased practice with the aspiration of mirroring the results of a previous study completed by
Milazi et al. in 2020. Milazi et al. (2020), determined that instituting patient teaching, consisting
of the 4Ds curriculum (diet, drinks, drugs, and dialysis), lowers serum phosphorus levels in those
suffering from hyperphosphatemia. Controlling phosphorus is crucial for ESRD patients, as
those with uncontrolled hyperphosphatemia have a mortality risk between eight and twenty times
greater than those with a phosphorus level within normal limits (Fishbane & Nigwekar, 2021).
Over eight weeks, using a step-by-step approach, this project was implemented with the
objective of increasing adherence levels to diet, drinks, drugs, and dialysis (4Ds) in the chronic
outpatient hemodialysis population in the pursuance of achieving and maintaining blood serum
phosphorus levels between 3.0 and 5.5 mg/dL.
1. Increase adherence levels to diet, drinks, drugs, and dialysis in ESRD patients.
a. Broaden patient knowledge of phosphate in end-stage renal disease.
b. Support patient self-efficacy for managing phosphate levels.
c. Increase patient adherence to prescribed treatment regimens (Diet, Drinks, Drugs, and
Dialysis).
2. Achieve and maintain a serum phosphorus level between 3.0 and 5.5 mg/dL in chronic
outpatient hemodialysis patients.
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Review of Literature
A literature review was conducted with the following primary considerations: 1) Best
practice for controlling phosphorus in patients with ESRD; 2) Hyperphosphatemia in those
currently receiving hemodialysis.
The databases utilized were CINAHL, PubMed, and PsycINFO using master headings
and mesh headings. The following key terms were used in CINAHL: hyperphosphatemia, endstage renal disease, and hemodialysis. A total of 317 potential sources were found. Results were
narrowed using peer-reviewed, academic journals, and within the last five years, reducing the
potential sources to 18 total findings. Additional articles were eliminated due to content
irrelevance, if they were not available in English, or if the interventions did not occur within an
outpatient setting resulting in 13 articles. The key terms were applied in PubMed which resulted
in 1,766 findings. The same inclusion and exclusion criteria were applied to these articles.
References of the selected papers were also searched and evaluated for application to the study
question. Results were narrowed using a limit of five years which resulted in a total of 39
findings. The key terms were applied in PsycINFO which resulted in 1,795 findings. The
inclusion and exclusion criteria were applied to these articles. References of the selected papers
were also searched and evaluated for application to the study question. Results were narrowed
using a limit of five years which resulted in a total of 53 findings. Many of the key findings from
the literature review included systematic reviews, randomized clinical trials, and quantitative
studies. Some of the significant key findings used to shape the methodology of this project are
identified below.
Umeukeje et al. (2018) performed a systematic review to determine factors relevant for
adherence to phosphate-control strategies in dialysis patients and to explore interventions to
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overcome related challenges. The review concluded that compliance with phosphate binders, a
low-phosphorus diet, and dialysis prescription is suboptimal at best (Umeukeje et al., 2018). It
furthermore concluded that a multicomponent approach simultaneously addressing therapyrelated attributes, such as side effects, patient factors targeting self-motivation, and provider
components to improve attitudes and delivery of culturally sensitive care, may present the most
promise for long-term control of phosphorus levels (Umeukeje et al., 2018). Moreover, the
review stressed the importance of identifying those patients at the highest risk for lack of
phosphorus control (Umeukeje et al., 2018). These factors include younger age, elderly, nonCaucasian race, poor social-economic status, and unmarried (Umeukeje et al., 2018). In
addition, programs should be ready to deliver flexible person-centered plans through training and
steadfast resources to correlate with the needs of all patients (Umeukeje et al., 2018).
Milazi et al. (2017) performed a systematic review evaluating the effects of educational
and behavioral interventions on achieving phosphate control in adults on hemodialysis. A total
of eighteen studies were included in the review which found that both educational and behavioral
interventions do increase adherence to phosphate control in this population (Milazi et al., 2017).
Chan et al. (2019) performed a quantitative study to investigate the efficacy of a
multidisciplinary education approach to achieving optimal phosphate control among patients on
hemodialysis in Malaysia. The authors used a single-arm community trial with a duration of 6
months (Chan et al., 2019). Fifty-seven subjects participated in a small group seminar and
individual counseling sessions emphasizing diet and medication adherence (Chan et al., 2019).
The educational topics presented in the seminars included basic knowledge about
hyperphosphatemia, phosphate binders, and dietary phosphate control (Chan et al., 2019). After
completion, the percentage of participants with uncontrolled serum phosphorus levels decreased
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from 59.3% to 35.6%, knowledge of hyperphosphatemia increased drastically, and adherence to
phosphate binders improved from 17.2% to 41.4% (Chan et al., 2019). The authors concluded
that a multidisciplinary patient education program is a viable strategy to manage
hyperphosphatemia among patients with hemodialysis (Chan et al., 2019).
Milazi et al. (2020) performed a randomized, controlled trial to evaluate the effectiveness
of a bundled self-management intervention (taking control of your phosphate with the 4Ds) on
phosphate control among adults receiving hemodialysis who had experienced uncontrolled
hyperphosphatemia for at least the past three months (Milazi et al., 2020). The “teach-back”
method was utilized to increase participant knowledge of the relationship between phosphate and
ESRD in the control group, resulting in 46% of the intervention group achieving reductions that
met the target serum phosphate level compared to 33% in the control group (Milazi et al., 2020).
The authors concluded that a 4Ds teaching curriculum is an effective tool for improving patient
assurance and adherence to phosphate control methods (Milazi et al., 2020).
Chiang et al. (2020) performed a quasi-experimental study to determine if an
individualized dietary phosphorus control program delivered by a smartphone application would
be effective in achieving phosphorus control in patients on hemodialysis in Taiwan. Sixty
participants were included with 30 using the program and the remainder participating in
traditional education. The experiment concluded that knowledge of diet phosphate control, selfcare efficacy in managing phosphorus, and serum phosphorus control were all improved with the
individualized program (Chiang et al., 2020).
Isa et al. (2020) performed a cross-sectional study in Malaysia to determine the barriers
between outpatient hemodialysis patients and phosphate compliance. Using a printed
questionnaire, the study asked participants questions related to their knowledge of optimal
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control of serum phosphate, perceived social support with phosphate compliance (family and
professional), and average dietary phosphorus intake. (Isa et al., 2020). A total of seventy-six
participants were enrolled in the project. Approximately 60% of the patients enrolled were
currently failing to achieve the target serum phosphorus level at the time of the study, which
confirmed that hyperphosphatemia is prevalent among hemodialysis patients (Isa et al., 2020). It
also noted that half of the participants had a low level of knowledge regarding optimal control of
serum phosphate (Isa et al., 2020). The study recommended that healthcare professionals engage
in regular nutritional screening and counseling among those patients not meeting phosphate
adequacy in pursuance of achieving better outcomes (Isa et al., 2020). The study also
recommended developing new and innovative approaches with the aspiration of encouraging
self-adherence to serum phosphate control for those receiving chronic hemodialysis (Isa et al.,
2020).
Brauer et al. (2019) instituted a study using phosphate education and planning (PEP) talks
to determine the effect on the incidence of hyperphosphatemia in patients receiving
hemodialysis. All forty-six participants received four PEP talks discussing long-term
management of serum phosphate levels resulting in a mean decrease in serum phosphate by 0.31
mg/dL. Self-identified participant barriers to achieving phosphate control included a lack of
customization of phosphate binder prescriptions and an insufficient resource for suitable dietary
changes. The study furthermore concluded that the PEP talks were an effective intervention to
aid in managing persistent hyperphosphatemia in those receiving chronic hemodialysis (Brauer
et al., 2018).
Tsai et al. (2016) conducted a study to determine if staff-led diet education which
included input from a dietician improved patient phosphorus levels in patients on hemodialysis.
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The study was conducted over eight months and had sixty-one participants. The control group
received routine dietetic education from nurses and physicians, while the intervention group
received the same routine dietetic education as well as added reinforcement education from
dieticians. Both groups experienced decreases in blood serum phosphorus levels, with the
greatest decrease found in the group receiving teaching that included a dietician. Authors
concluded that renal diet education guided either by dietitians plus dialysis staff or dialysis staff
alone reduces serum phosphorus levels, with the multidisciplinary approach providing slightly
better outcomes (Tsai et al., 2016).
Lim et al. (2018) performed a randomized, controlled trial to study the effects of
education on a low-phosphorus dietary adherence and phosphorus binder adherence to control
serum phosphorus among those receiving regularized hemodialysis treatments. The study
enrolled maintenance hemodialysis patients and then randomized them into an education group,
consisting of forty-eight participants, and a control group consisting of twenty-two participants
(Lim et al., 2018). After completion, 75% of the intervention group achieved the primary goal
compared to 72.7% of the control group (Lim et al., 2018). The study did show limited success
in compliance with dietary phosphorus restriction and phosphate binder adherence but ultimately
concluded that education did not affect blood serum phosphorus control in those receiving
regular maintenance hemodialysis (Lim et al., 2018).
Karavetian and Rizk (2018), state that rather than finding new treatments for
hyperphosphatemia, the most effective intervention is to deliver existing therapies more
effectively. This writing specifically argues against the previous study performed by Lim et al.
(2018) by acknowledging the limitations of the work (Karavetian & Rizk, 2018). Karavetian and
Rizk (2018), suggest that both patient-tailored counseling and adequate time with a clinician
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improve serum phosphate control when consistently reinforced. Stating that patient education
programs can provide valuable opportunities for containing costs in terms of adequate
phosphorus control (Karavetian & Rizk, 2018).
Theoretical Model
In 1951, Kurt Lewin developed “Lewin’s Theory of Planned Change”. This groundbreaking theory is composed of three core components (steps): Unfreezing, Changing, and
Refreezing (Lewin, 1951). Unfreezing occurs before the change is implemented and focuses on
creating problem awareness (Lewin, 1951, as cited in Wojciechowski et al., 2016). Changing
occurs when the change is in place, and Refreezing occurs after the change (Lewin, 1951). This
stage focuses on ensuring that the change will become permanent (Lewin, 1951, as cited in
Wojciechowski et al., 2016).
Lewin's Theory of Planned Change was the model chosen for this project based on its
alignment with the project objective, which is change. Another reason that this model was
chosen was because of its simplistic nature. This project can be broken down into the three basic
components of change presented in Lewin’s theory. During the Unfreezing stage, participants
will be made aware of the problem of hyperphosphatemia through education. In the Changing
stage, coaching and training will occur on how correct the hyperphosphatemia. During this
stage, participants will seek alternatives to their current behaviors and implement them
throughout their daily processes. And lastly, in the Refreezing stage, the newly integrated
changes will become a permanent habit. During this stage, reiteration may occur as well as the
celebration of success.
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Methodology
This was an eight-week quality improvement project aimed at decreasing the incidence of
hyperphosphatemia in the chronic outpatient hemodialysis setting. The project used a
quantitative quasi-experimental design method with purposive sampling for data collection. The
rationale for choosing this design method was to reach as many willing participants as possible
in the project’s setting. The primary objective of this project was to increase adherence levels to
diet, drinks, drugs, and dialysis (4Ds) in those receiving chronic outpatient hemodialysis in the
pursuance of achieving and maintaining blood serum phosphorus levels between 3.0 and 5.5
mg/dL as recommended by the Centers for Medicare and Medicaid Services. Upon initiation of
this project, all participants had a blood serum phosphorus level greater than 5.5 mg/dL. Thus,
100% of the participants had a diagnosis of hyperphosphatemia. This information was based on
each of the participant’s latest lab draw results which were a part of routine care provided by the
clinic and occurred one week before project initiation.
Setting
The project was conducted at a chronic outpatient hemodialysis unit in an urban area in
Central Alabama. Staff at the unit included one physician, one nurse practitioner, one clinic
manager, one dietician, one social worker, one facility assistant, one biomedical technician, two
registered nurses, and six certified clinical hemodialysis technicians. Patients at the clinic are
seen once monthly by the physician, three times a month by the nurse practitioner, and weekly
by the dietitian and social worker; every treatment is performed by a registered nurse and
certified clinical hemodialysis technician.
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Population
The target population for this project consisted of patients with blood serum phosphate
levels greater than 5.5 mg/dl between the ages of 20- and 80 years receiving outpatient
hemodialysis at the outpatient hemodialysis center. The unit had 24 chairs, dialyzes three
separate shifts of patients per day, and runs three days per week. The first shift was composed of
24 patients, the second shift was also composed of 24 patients, and the third shift had two
patients. This made a total of 50 possible candidates for the project.
Inclusion/Exclusion Criteria for Participants
The following were the inclusion and exclusion criteria for participants in this project:
Inclusion Criteria: Patients eligible for inclusion in this study had the following
characteristics.
•

20 to 80 years of age

•

Receiving chronic outpatient hemodialysis at the time of the study

•

Measured serum phosphorus level greater than 5.5 mg/dL

•

Fluent in English

Exclusion Criteria:
•

Residency within a long-term care facility (e.g., nursing home).

•

Current diagnosis of delirium or dementia (e.g., Alzheimer's, dementia, delirium).

Recruitment
Based on the project’s inclusion and exclusion criteria, a list of potential candidates was
presented to the principal investigator (PI) by the unit dietician. Recruitment was done on a
face-to-face basis by the principal investigator (PI). After determining which candidates were
eligible for the project, the PI approached each potential participant while he or she was

23
receiving his or her hemodialysis treatment. The PI verbally explained the project and its
purpose to each potential candidate by reading and referring to the information in the project
consent form (Appendix A). Each potential candidate was offered a project consent form for
reading at his or her discretion, then allowed as much time as needed to decide. It was
emphasized that there was no pressure in deciding whether to or whether to not participate in this
study.
Consent
Written consent was obtained from all study participants before project intervention
(Appendix A). It was iterated to all potential participants that the goal of this project was to
lower the incidence of hyperphosphatemia in the chronic outpatient hemodialysis setting.
Participants were notified that participation was strictly voluntary and that they could withdraw
from the study at any point without penalty.
Design
This project was implemented to increase adherence levels to diet, drinks, drugs, and
dialysis (4Ds) in the chronic outpatient hemodialysis population. This quality improvement
project was completed with the aspiration of achieving and maintaining blood serum phosphorus
levels between 3.0 and 5.5 mg/dL. The project was conducted to determine if the 4Ds patient
teaching intervention had an impact on any of the following factors: (1) a patient’s knowledge of
phosphorus (2) a patient’s blood serum phosphorus level, and (3) a patient’s compliance with
dialysis treatments.
Participants in the project were given a pre-curriculum phosphorus assessment composed
of twenty multiple-choice questions covering the content to be taught throughout the project
(Ford et al, 2004) (Appendix B). The questionnaires were scored by the PI and recorded on a
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spreadsheet (Appendix C). After completing a baseline knowledge assessment, participants
participated in face-to-face, one-on-one educational sessions provided by the principal
investigator and the clinical dietician at each of their regularly scheduled hemodialysis sessions.
There was a total of four steps to the education with newly presented content limited to no more
than five minutes in duration. During the first three dialysis sessions, participants were educated
on the dangers and health issues related to uncontrolled hyperphosphatemia. During the next
three dialysis sessions, participants were educated on popular foods and drinks containing higher
phosphorus content. During the following three dialysis sessions, participants were educated on
the importance of taking their phosphorus-controlling medications as prescribed. During the
next three dialysis sessions, participants were educated on the importance of attending all their
dialysis treatments in their entirety. These concepts build on one another, thus a comprehensive
review of previously discussed content occurred weekly. This accounted for the first four weeks
of the project, then repeated in its entirety during the second four weeks of the project.
The impact of education was assessed based on three outcomes: blood serum phosphorus
levels post-education sequence, repeat questionnaires post-education sequence, and dialysis
treatment adherence rates post-education sequence. Once complete, blood serum phosphorus
levels were drawn before each participant's next dialysis treatment. The pre-intervention and
post-intervention serum phosphorus levels were then compared. Next, a post-intervention
questionnaire was administered, scored, and compared to the results of the pre-intervention
questionnaire. Lastly, pre-intervention dialysis treatment adherence rates and post-intervention
dialysis treatment adherence rates were compared.
The results were analyzed using descriptive statistics. Given the limited number of
available participants for this project, and to ensure ethical standards were held for all possible
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participants, only one group of participants was utilized for data analysis. Thus, to ensure
validity, a pre-/post measurement of data was obtained on the same group of participants. The
independent variable for this project was patient education and the dependent variables were
blood serum phosphorus levels and dialysis treatment adherence rates.
Chart Review
After gaining permission from the Institutional Review Board (IRB) (Appendix D) as
well as consent from the participating medical corporation a pre-intervention chart review was
performed to determine participant eligibility based on serum phosphorus levels. Out of the fifty
possible candidates for this project, 26 of those had a blood serum phosphorus level greater than
the target of 5.5 mg/dL. Of those possible 26 candidates, 10 did not meet the criteria, and six
refused project participation. This left a total sample size of 10 participants for the project.
There were three total chart reviews for this project: pre-intervention, 4-weeks into
intervention implementation, and 2-weeks after completion of the intervention (Appendix F).
The electronic health record (EHR) system utilized at this outpatient hemodialysis unit was
eCube Clinicals; this was the only system utilized in this project. Information was collected
from the EHR by the PI and the unit dietician. No names, dates of birth, or medical record
numbers were recorded from the EHR. The only data extracted from the EHR was each
participant’s blood serum phosphorus levels and dialysis treatment adherence rates. Each
participant was assigned a project-specific number based on the alphabetical order of their last
names. One hand-written list of these names and assigned numbers was created. This handwritten list along with the questionaries, blood serum phosphorus results, and dialysis treatment
adherence rates were locked in a file cabinet within the facility. The PI and the clinic dietician
were the only people involved in retrieving this data, and all the data was destroyed via
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shredding three weeks after project completion. No identifiable participant information was
disclosed during, after, or for the project at any time.
Risks and Benefits
Minimal to no expected harm could have occurred from participating in this project. The
main benefit of this project was lowering the incidence of hyperphosphatemia in the outpatient
hemodialysis community. If effective, this intervention/project could benefit the health of the
patients, their dialysis facilities (via higher QIP scores), and the overall cost of healthcare by
lowering the occurrence of the comorbidities associated with longstanding hyperphosphatemia.
Compensation
There was no compensation provided before, during, or after the project to either the
participants or the consenting medical corporation.
Timeline
Planning and proposal development for this project began in June of 2021. To ensure
that all standards of the research process were met, the PI completed the Collaborative
Institutional Training Initiative course in September of 2021 (Appendix E). In November of
2021, the Jacksonville State University Institutional Review Board awarded consent for the
project. Also in November of 2021, the outpatient hemodialysis unit where this project was
implemented granted the project a Letter of Support. Data collection and project implementation
occurred between January 2022 and March 2022. Data analysis for this project occurred
between January 2022 and April 2022. The project manuscript was written between April 2022
and June 2022. The results of this project were presented during the Jacksonville State
University’s Doctor of Nursing Practice Dissemination Day on July 15, 2022 (Appendix F).
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Budget and Resources
Total projected costs for this project were less than $600. This total included fees for
statistical analyses, writing consultation, unit staff involvement, and paper copies. The writing
consultation for this project was provided free of charge by Jacksonville State University. The
unit dietician volunteered her time for this project. The statistician for this project charged $150
for the data analysis portion and the copies for the project costs $20. This resulted in a total
actual cost of $170 for the project (Appendix G).
Evaluation Plan
Statistic Considerations
Descriptive statistics (means, standard deviations) were used to describe the
demographics of the study participants and changes in outcomes for this study. Non-parametric
tests were conducted to compare averages of all factors of interest due to the small sample size
available for this research. The Wilcoxon-signed rank test was used to analyze pre-and-post
questionnaire scores, serum phosphate levels, and hemodialysis treatment adherence rates. The
statistical software Minitab® 19 was used to perform all analyses.
Results
Intervention and Demographics
A total of ten participants met inclusion criteria and consented to participate in the study.
All participants were male with six (60%) selecting African American as their primary race and
four (40%) of the men selecting Caucasian. Figure 1 illustrates the participant breakdown by
race.
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Figure 1

The average age of participants was 60.5 with a standard deviation of 10.8. The youngest
participant was 46 years old, and the oldest participant was 78 years old. Figure 2 illustrates the
participant breakdown by age.
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Figure 2

Results of Participant Questionnaires
There was a statistically significant difference (W = 51.0, p = 0.019) between preassessment and post-assessment performance with the average pre-assessment score of 66 out of
100 (standard deviation of 19.1) and an average post-assessment score of 78 out of 100 (standard
deviation of 13.2). Figure 3 displays the scores of the Phosphorus Knowledge Assessment.
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Figure 3

Results of Blood Serum Phosphorus Levels
The average phosphorus level before the intervention was 7.3 mg/dL (standard deviation
1.5) with a mid-intervention level of 6.2 mg/dL (standard deviation of 2.2), and post-intervention
mean phosphorus level of 6.9 mg/dL (standard deviation of 2.4), though no statistical difference
was noted (H = 1.47, p = 0.479).
Results of Dialysis Treatment Compliance
Before the intervention, the average number of shortened sessions of hemodialysis
treatment (sessions started but not completed) was 3.2 over an eight-week time frame with a
standard deviation of 4.3, while the average number of shortened sessions after the intervention
was 2.2 with a standard deviation of 2.2, showing no statistical difference after intervention (W =
12.00, p = 0.441). Similarly, no difference in missed hemodialysis sessions was found before the
intervention was 0.8 with a standard deviation of 1.6 compared to 0.7 (standard deviation of 0.9)
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after the intervention Together, the results of both tests imply that the intervention had no impact
on dialysis treatment compliance rates.
Discussion
This project sought to address the lack of consistency in delivering patient teaching on
hyperphosphatemia in the outpatient hemodialysis population as it relates to compliance with
recommended blood serum phosphorus levels.
The main significant finding of this project was the increase in patient knowledge about
phosphorus, suggesting that the intervention increased patient awareness of the relationship
between phosphorus and ESRD. This furthermore demonstrates that regularized patient teaching
on phosphorus improves comprehension of basic concepts related to adequate phosphate control
in this population. These findings are similar to the existing data set forth by Milazi et al.
(2020).
However, the intervention did not prove effective in lowering the incidence of
hyperphosphatemia nor increasing compliance to prescribed treatment regimens. These two
desired outcomes are also equally important, if not more so important, than improving the
knowledge deficit in terms of long-term success. It is undetermined by the project why these
two outcomes were not met or what barriers prevented their obtainability during the project.
Consequently, the overall goal of this project was not met by the instituting of this intervention
in this sample of the outpatient hemodialysis population.
Implications for Clinical Practice
This project’s aims were partially met as evidenced by a greater patient knowledge base
of phosphorus. This included information such as the desired blood serum phosphate level as
well as how to physically obtain that goal. Although the other two objectives for this project
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were not met as anticipated, this information remains relevant in the battle against
hyperphosphatemia in the outpatient hemodialysis setting. This project can contribute to existing
evidence supporting that regularized patient teaching increases awareness of hyperphosphatemia
in this population.
Decreasing the incidence of hyperphosphatemia in the outpatient hemodialysis setting is
a long-term goal. As existing evidence suggests, motivational or standardized teaching practices
possess the potential to produce a positive effect on phosphorus control. As with anyone, ESRD
patients must be made aware of a problem before they can correct it. Increasing their knowledge
of phosphorus, or making them more phosphate aware, does just this. This project aided in
addressing the issue of hyperphosphatemia in this clinical setting. Through intervention, this
project increased awareness of this problem and therefore allowed its participants the opportunity
to correct it; if not immediately, then possibly in the future.
Implications for Healthcare Policy
While there are standards in place concerning the desired goal of blood serum
phosphorus levels in ESRD patients by dialysis corporations and the Centers for Medicare and
Medicaid Services, there is currently no policy in place on how to achieve this outcome
adequately and consistently. This project further exemplifies the knowledge deficit of
phosphorus control in the outpatient hemodialysis setting. This single inadequacy could be a
primary factor in the current shortcomings of bone and mineral health in this population. It is for
this reason that the results of this project, as well as existing evidence, could be used as a
cornerstone in the argument for future policy creation.
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Implications for Quality
This quality improvement project demonstrated an increased initiative with staff-led
patient education. The teaching occurred consistently with each participant receiving
educational sessions three times per week during their regularly scheduled hemodialysis
treatments throughout the entirety of this project. This consistency was only compromised if a
participant missed a treatment. While the PI and the facility dietician were the only two staff
involved with patient teaching during this project, other adjunct staff showed interest in
participating in any future endeavors. Some of the participants also showed initiative by
welcoming each session for new information in addition to enjoying the fellowship with the
staff. Implementing this intervention company-wide could show promise in improving the
quality of care delivered by decreasing the knowledge gap associated with hyperphosphatemia
while inviting patient-to-staff interaction.
Implications for Education
Similar studies have displayed the effectiveness of patient education in relation to
improving phosphate control among hemodialysis patients. While this project does not support
this evidence in its entirety, it does, however, further support the concept of patient education as
a means of increasing knowledge of phosphate control in this setting. This is evident in the
improved post-intervention questionnaire scores after project completion. After conclusion,
median questionnaire scores rose by 12 points, from 66 pre-intervention to 78 post-intervention.
Limitations
The two main limitations of this project were its sample size and its time constraints. The
sample size was very small in contrast to the number of patients with ESRD who also suffer
from hyperphosphatemia. Due to the project’s exclusion criteria as well as participant refusal,
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the sample size was only composed of ten people, all of whom were men, and which only
accounted for two ethnicities (African American and Caucasian). Also, given the limited
number of eligible and willing participants for this project, only one group of participants was
utilized for data analysis. Because of this, to ensure validity, a pre-/post measurement of data
was performed on the same group of participants. This means the control group was the
intervention group, only at two different intervals in time: pre-intervention and post-intervention.
Had this project been implemented at a larger outpatient hemodialysis clinic or with multiple
clinics simultaneously, the outcomes may have differed tremendously. This would have allowed
for a separate control group as well as greater diversity within the project sample.
Time constraints also limited the results of this project. This was a short-term project
which could only demonstrate short-term effects. This project was completed over only an
eight-week time interval, whereas the study it was mirroring by Milazi et al. (2020) was
completed over a twelve-week time interval. As previously stated, decreasing the incidence of
hyperphosphatemia in the outpatient hemodialysis setting is a long-term goal. Therefore, a
longer-term intervention may show more success in decreasing blood serum phosphorus levels
and improving adherence rates to dialysis prescriptions, like that of the study by Milazi et al.
(2020). Given this project’s results, it is unclear if a longer intervention interval would or would
not be beneficial.
Dissemination
The findings for this project will be disseminated via poster, presentation, and paper.
This paper will be presented at Jacksonville State University’s Annual Virtual Dissemination
Day by either poster or presentation on July 15, 2022. This paper will also be presented at the
agency where the project was implemented.
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Sustainability
This project did not end after completion. The findings of this project were presented
during a monthly Quality Assurance and Improvement Committee meeting at the facility where
it was implemented. The members of this local Quality Assurance and Improvement Committee
are currently reviewing the results of this project. If the findings of this project are found to be
significant by this committee, the paper will be forwarded to the company’s corporate office.
Then, if deemed appropriate by corporate officials, a company-wide written policy will be
created standardizing staff-led patient phosphate control education. If this intervention becomes
a policy, it will be instituted nationally.
Plans for Future Scholarship
While this project adds to the existing data supporting the utilization of regularized
patient education to increase awareness of phosphate control in the ESRD population, further
research is warranted to determine if this intervention can decrease the incidence of
hyperphosphatemia for these patients on a long-term basis. Future studies could aid in
determining the significance of this project’s findings as well as help to ascertain if the
limitations of this project are substantial enough to alter patient outcomes. The small sample size
of this project leaves notable gaps in patient demographics. Different age groups, genders, and
ethnicities may benefit more from this intervention than others. Future studies could assist in
discovering this and additionally determine whether the time limitations of this project
contributed to its outcomes or lack thereof.
Hyperphosphatemia has been a pinnacle problem in the outpatient hemodialysis setting
for years. Thus, underlying barriers may contribute to the lack of success in mastering this issue.
Future endeavors could aid in identifying and addressing these barriers. This project only
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utilized a staff floor nurse and the facility dietician. More success may be possible if the patient
care technicians and other adjunct staff delivered patient education as well. If there are more
people involved, there may be greater success.
Conclusion
Hyperphosphatemia (excess phosphate in the blood) is a problem that continually causes
health issues for the outpatient hemodialysis population. According to Rastogi et al. (2021), by
the time a patient begins hemodialysis, statistics reflect many of them will already have
hyperphosphatemia and the trend continues thereafter. Multiple studies have documented the
adverse effects related to hyperphosphatemia in the ESRD population, as well as how to best
correct this issue, however, the problem remains. Controlling a patient’s phosphorus level can
be challenging to providers, given that so much of it is dependent upon patient adherence. One
study by Karavetian and Rizk (2018), found that instituting a regularized patient education
program as a primary intervention proved effective in lowering phosphorus levels in the ESRD
population. Over eight weeks, using a step-by-step approach, this project was implemented with
the objective of increasing adherence levels to diet, drinks, drugs, and dialysis (4Ds) in the
chronic outpatient hemodialysis population in the pursuance of achieving and maintaining blood
serum phosphorus levels between 3.0 and 5.5 mg/dL.
The main significant finding of this project was the increase in patient knowledge about
phosphorus. Results of the project showed sufficient evidence that the median postquestionnaire score was significantly higher compared to the median pre-intervention score.
However, the intervention did not prove effective in lowering the incidence of
hyperphosphatemia nor increasing compliance to prescribed treatment regimens. The two main
limitations of this project were its sample size and its time constraints.
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While this project adds to the existing data supporting the utilization of regularized
patient education to increase awareness of phosphate control in the ESRD population, further
research is warranted to determine if this intervention can decrease the incidence of
hyperphosphatemia for these patients on a long-term basis. Future studies could aid in
determining the significance of this project’s findings as well as help to ascertain if the
limitations of this project are substantial enough to alter patient outcomes. Hyperphosphatemia
has been a pinnacle problem in the outpatient hemodialysis setting for years. Thus, underlying
barriers may contribute to the lack of success in mastering this issue. Future endeavors could aid
in identifying and addressing these barriers.
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Appendix A
Participant Consent Form
TITLE OF STUDY: Implementing the 4Ds (diet, drinks, drugs, and dialysis) to lower
hyperphosphatemia among outpatient hemodialysis patients
Principal Investigator: Morgan Atchison, MSN, RN
This consent form is part of an informed consent process for a Doctor of Nursing Practice (DNP)
student project, and it will provide information that will help you decide whether you wish to
volunteer for this project. It will help you to understand what the study is about and what will
happen during the project.
If you have questions at any time during the project, feel free to ask them with the expectation to
be given answers that you understand entirely.
Why is this project being done?
Hyperphosphatemia is a problem that affects the outpatient hemodialysis population. This could
be related to a lack of patient knowledge concerning the negative effects of hyperphosphatemia
on the body as well as how to effectively control phosphorus levels due to only receiving
randomized teaching. The purpose of the project will be to implement regularized patient
teaching to those currently receiving outpatient hemodialysis who also suffer from
hyperphosphatemia on the 4Ds criteria (diet, drinks, drugs, and dialysis) in the pursuance of
achieving targeted serum phosphorus levels of 3.0 to 5.5 mg/dL over the next eight weeks.
What will you be asked to do if you take part in this DNP project?
Participants will be asked to complete a pre-intervention phosphorus knowledge questionnaire.
This will be a short, concise multiple-choice quiz. After which, participants will receive one-onone teaching throughout the next eight weeks on controlling their blood serum phosphorus level.
Once the eight-week curriculum is completed, participants will be asked to complete a postintervention phosphorus knowledge questionnaire.
Outcomes of this project will be based on three factors: blood serum phosphorus levels postintervention, repeat questionnaires post-intervention, and dialysis treatment adherence rates postintervention.
By agreeing to be a part of this project you are giving your consent for the principal investigator
(Morgan Atchison) to view, record, and use the results of your pre-and-post intervention serum
phosphorus levels and pre-and-post intervention dialysis treatment adherence rates. These
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results will not contain your name or any identifying information and will remain completely
confidential at all times.
What are the potential benefits of this project?
The main benefit of this project is lowering the incidence of hyperphosphatemia in the outpatient
hemodialysis community. If proven effective, this intervention/project could benefit the
participants, their dialysis facilities, and the cost of healthcare by lowering the occurrence of the
comorbidities associated with longstanding hyperphosphatemia.
What are the risks or discomforts you might experience if you take part in this project?
No expected harm can occur from participating in this project. Participation in this project is of
no cost to you.
How will information about you be kept private or confidential?
All efforts will be made to keep your personal information confidential. No identifiable
participant information will be disclosed during, after, or for the project at any time. Participants
will be numbered; thus, your name will remain confidential. Questionnaires, lab results, and
treatment adherence rates will remain locked within the facility, and information will not be
removed from the premises unless all identifiable information has been removed. Once the
project is completed, these records will be permanently destroyed via shredding.
What will happen if you do not wish to participate in the project or if you later decide not
to stay in the project?
Participation in this project is voluntary only. Thus, either consent or non-consent to
participation in the project will not affect your current treatment regimen or facility demeanor in
any positive nor negative form. If you decide to stop participating, you have the right to
discontinue the project and withdraw consent at any time during the project without reproach or
discrimination. We do however request a written statement withdrawing your consent.
Where will this project be done?
Right here at your dialysis facility during your assigned treatment time. It should be noted
however that this is an independent project that is in no way affiliated with Fresenius Kidney
Care.
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Who can you call if you have any questions?
If you have any questions about taking part in this project, you can call or write the principal
investigator:
Morgan Atchison, MSN, RN
Fresenius Kidney Care – Cahaba Valley
120 Cahaba Valley Parkway, Suite 150
Pelham, AL 35124
(205)-988-0469
matchison@stu.jsu.edu

X

Participant Signature

X

Witness Signature
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Appendix B
Phosphorus Knowledge Assessment Participant Questionnaire

Phosphorus Knowledge Assessment

Patient #

1. Good phosphorus control depends on:
a. Dialysis
b. Diet
c. Taking a phosphorus binder with meals
d. All of the above
2. Which of the following foods are high in phosphorus?
a. Tomatoes
b. Rice
c. Milk
d. Green beans
3. Which of the following may happen when phosphorus levels are too high?
a. Itching
b. Dizziness
c. Irregular heartbeat
d. Cramping
4. What happens when your phosphorus levels are high?
a. Calcium in your blood will get low
b. Calcium is taken out of your bones
c. Your bones may become weak
d. All of the above
5. Which of the following contains the most phosphorus?
a. Whole milk
b. 2% milk
c. Skim milk
d. All of the above
6. When should you take your binder?
a. Between Meals
b. 8 am, 12 pm, and 6 pm
c. With all meals and snacks
d. Before bedtime
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7. What is the best way to control your phosphorus?
a. Taking your binder
b. Consistently following your diet
c. Starving yourself
d. A & B
8. Which of the following foods is low in phosphorus?
a. Cheese
b. Milk
c. Potatoes
d. Coke
9. What is the desired level for phosphorus?
a. > 8
b. < 6
c. > 11
d. < 1
10. How much phosphorus should you eat in foods in one day?
a. 4000 mg
b. 1000 mg
c. 12 mg
d. 300 mg
11. Which of the following problems can develop if the amount of phosphorus in your blood
is increased?
a. Liver disease
b. High blood pressure
c. Bone disease
d. Heart disease
12. Why should you cut back your dietary intake of phosphorus?
a. There is no reason to cut back the dietary intake of phosphorus.
b. Because your kidneys cannot properly clear phosphorus from your body.
c. Because your liver cannot properly clear phosphorus from your body.
d. You should increase your intake of phosphorus.
13. Which of the following foods contain large amounts of phosphorus?
a. Fruits such as strawberries, bananas, and oranges.
b. Dairy products, meat, and cola beverages.
c. Bread, pasta, and rice.
d. Vegetables such as carrots, green beans, and corn.
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14. What are phosphate binders?
a. Medications that decrease the level of potassium in your body.
b. Medications that increase the level of magnesium in your body.
c. Medications that decrease the level of phosphorus in your body.
d. Medications that decrease the level of calcium in your body.
15. Complete the statement: “Phosphate binders work by . . .”
a. Preventing potassium from entering your body in the stomach.
b. Allowing phosphorus to enter the body in the stomach.
c. Preventing calcium from entering your body in the stomach.
d. Preventing phosphorus from entering your body in the stomach.
16. Which of the following is a phosphate binder?
a. Rolaids
b. Mylanta
c. Tums
d. Alka-Seltzer
17. All of the following bind phosphorus EXCEPT:
a. Calcium
b. Zinc
c. Aluminum
d. Magnesium
18. Which of the following foods is low in phosphorus?
a. Rice
b. Yogurt
c. Cheese
d. Pecans
19. Which of the following foods is high in phosphorus?
a. Apples
b. Watermelon
c. Peanut butter
d. Peaches
20. Who is responsible for your phosphorus control?
a. The doctor
b. You
c. The dietitian
d. The nurse
*This questionnaire was provided with permission from Ford et al. (2004). The test will be
administered pre-and-post intervention. Bold responses represent the best answer.
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Appendix C
Pre- and-Post-Questionnaire Tracking Form
Patient Number of
ID
Questions
Number Answered
Correctly
PreIntervention

Number of Total Score
Questions
PreAnswered
Intervention
Incorrectly
PreIntervention

Number of
Questions
Answered
Correctly
PostIntervention

Number of Total Score
Questions
PostAnswered
Intervention
Incorrectly
PostIntervention
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Appendix D
Letter of Approval by the Jacksonville State University Institutional Review Board
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Appendix E
CITI Training Completion Report
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Appendix F
Project Timeline
TASK (06/21-07/22)

JUN

JUL

AUG

SEP

OCT

NOV

DEC

Project
planning/proposal
development
Proposal Approval
by PERC*
Obtain Agency Letter
of Support
JSU IRB**
Submission/Approval
Implementation
Data Collection
Data Analysis
Writing DNP
Manuscript Results,
Discussion, and
Implications
Final Presentation
and Dissemination

*Project Ethical Review Committee
**Jacksonville State University Institutional Review Board

JAN

FEB

MAR

APR

MAY

JUN

JUL
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Appendix G
Project Budget and Resources Form
PROGRAM EXPENSE

PROJECTED COST
$500.00

ACTUAL COST
$150.00

Start-up costs (copies, charts, displays)

Less than $100.00

$20.00

Capital costs (hardware, equipment)

$0.00

$0.00

Operational costs (heat/electricity)

$0.00

$0.00

Other: None expected

$0.00

$0.00

Total Project Expenses

Less than $600.00

$170.00

Salaries, wages (Admin support, practitioners,
statistics, or writing consultation)

